Advanced Search

Show simple item record

dc.contributor.authorCetin, Abdurrahman
dc.contributor.authorBiltekin, Burcu
dc.date.accessioned2021-03-31T20:25:27Z
dc.date.available2021-03-31T20:25:27Z
dc.date.issued2019
dc.identifier.issn1878-8750
dc.identifier.issn1878-8769
dc.identifier.urihttps://doi.org/10.1016/j.wneu.2019.08.228
dc.identifier.urihttps://hdl.handle.net/20.500.12900/36
dc.descriptionCetin, Abdurrahman/0000-0002-5246-7652en_US
dc.descriptionWOS:000496966300022en_US
dc.descriptionPubMed: 31505280en_US
dc.description.abstractOBJECTIVE: We aimed to evaluate the combined effect of ellagic acid (EA) and temozolomide (TEM) on the cadherin switch and angiogenesis in the C6 glioma cell line. METHODS: A total of 100 mu M EA and 100 mu M TEM were applied to rat C6 glioma cells for 24, 48, and 72 hours. Cell proliferation was detected by 5-bromo-2'-deoxyuridine immunohistochemistry. The messenger RNA and protein levels of E-cadherin, N-cadherin, and vascular endothelial growth factor (VEGF) were determined by real-time polymerase chain reaction and their immunohistochemistry, respectively, subsequent to EA treatment combined with TEM. RESULTS: EA in combination with TEM conspicuously reduced the viability of C6 glioma cells at all incubation times (P < 0.001). EA upregulated the expression of E-cadherin at the gene and protein levels in a time-independent manner (P < 0.05 and P < 0.001, respectively). By the presence of TEM, the increase was exaggerated at 24-hour incubation (P < 0.01). Conversely, EA reduced N-cadherin expression and immunoreactivity in a time-independent manner (P < 0.05 and P < 0.001, respectively), and combination with TEM enhanced this effect at the 24th hour (P < 0.001). Combination also downregulated the gene expression (P < 0.001) and immunoreactivity of VEGF only at 72 hours (P < 0.001). CONCLUSIONS: A successful therapeutic efficacy of EA combined with TEM is suggested probably by inhibiting the cadherin switch and angiogenesis.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Incen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCancer therapyen_US
dc.subjectEllagic aciden_US
dc.subjectGlioblastomaen_US
dc.subjectTemozolomideen_US
dc.titleCombining Ellagic Acid with Temozolomide Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma Modelen_US
dc.typearticleen_US
dc.departmentİstanbul Atlas Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.department-temp[Cetin, Abdurrahman] Gazi Yasargil Educ & Rcsearch Hosp Hlth Sci Univ, Dept Neurosurg, Diyarbakir, Turkey; [Biltekin, Burcu] Istanbul Atlas Univ, Med Fac, Dept Histol & Embryol, Istanbul, Turkeyen_US
dc.contributor.institutionauthorBiltekin, Burcu
dc.identifier.doi10.1016/j.wneu.2019.08.228
dc.identifier.volume132en_US
dc.identifier.startpageE178en_US
dc.identifier.endpageE184en_US
dc.relation.journalWorld Neurosurgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record